Results 181 to 190 of about 6,938 (195)
Some of the next articles are maybe not open access.

CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L.

The American journal of pathology, 1999
CD95(Fas/APO-1)-ligand (CD95L) mediates apoptosis by trimerization of the CD95 receptor on the surface of sensitive cells. In vitro studies have shown CD95L expression mainly by activated T cells and suggested a role for CD95L in the regulation of immune responses. Little is known, however, about the cellular distribution of CD95L in situ in the normal
J, Sträter   +6 more
openaire   +1 more source

Characterization of CD95 Ligand (CD95L)-induced Apoptosis in Human Tenon Fibroblasts

Experimental Eye Research, 2002
Toxic side effects of cytotoxic agents such as 5-fluorouracil or mitomycin-C in glaucomatous filtering procedures call for alternative approaches to control fibroblast proliferation. CD95L is a death ligand that triggers apoptosis in susceptible target cells. Apoptosis allows for the safe disposal of cells without damaging the surrounding tissue.
Hueber, Arno   +6 more
openaire   +3 more sources

CD95L/FasL and TRAIL in Tumour Surveillance and Cancer Therapy

2006
The membrane-bound death ligands CD95L/FasL and TRAIL, which activate the corresponding death receptors CD95/Fas, TRAILR1 and TRAILR2, induce apoptosis in many tumour cells, but can also elicit an inflammatory response. This chapter focuses on the relevance of CD95L/FasL and TRAIL for the tumour surveillance function of natural killer cells and ...
openaire   +2 more sources

CD95L

AfCS-Nature Molecule Pages, 2005
Cornelius Fritsch   +2 more
openaire   +1 more source

CD95L antibody improves recovery in SCI

The Lancet Neurology, 2004
openaire   +1 more source

CD95L Confers Immune Priviledge to Liver Grafts Which Are Spontaneously Accepted

Transplantation Proceedings, 1998
F, Fändrich   +5 more
openaire   +2 more sources

CD95L.

Journal of biological regulators and homeostatic agents, 2000
openaire   +1 more source

Home - About - Disclaimer - Privacy